SWITCH project: Definition of treat-to-target criteria for shared decision making between patients and physicians about initiating, continuing or switching systemic treatment for chronic prurigo and chronic pruritus

SWITCH project: Definition of treat-to-target criteria for shared decision making between patients and physicians about initiating, continuing or switching systemic treatment for chronic prurigo and chronic pruritus - SWITCH project

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032616

Enrollment

400

Registered

2023-09-26

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L28.1 L28.2

Interventions

Group 1: Part 1: 150 subjects at the coordinating center in Münster, Germany (visit and filling in questionnaires) Part 2: 100 patients in external centers (visit and filling in questionnaires) Par

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with chronic prurigo and in Part 3: chronic pruritus

Exclusion criteria

Exclusion criteria: Limitations in the understanding of the German language

Design outcomes

Primary

Measure	Time frame
Define treatment criteria to guide systemic therapy in adults with mild, moderate to severe chronic prurigo and patients with chronic pruritus	—

Countries

Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Poland, Portugal, Russia, Singapore, South Korea, Spain, Sweden, Switzerland, United States

Contacts

Public ContactSonja Ständer

Universitätsklinikum Münster

Sonja.staender@ukmuenster.de+49-251-8357458

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 27, 2026